HPRT Antibodies

Santa Cruz Biotechnology features a diverse variety of HPRT monoclonal antibodies for research applications. HPRT monoclonal antibodies are suitable for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Hypoxanthine-guanine phosphoribosyltransferase (HPRT) is a key enzyme in the purine salvage pathway, enabling purine recycling for nucleotide synthesis. HPRT maintains cellular nucleotide pools and has been extensively studied in relation to genetic disorders. Mutations in HPRT can lead to Lesch-Nyhan syndrome, resulting in severe neurological and behavioral complications. Research focusing on HPRT has enhanced understanding of metabolic diseases and potential therapeutic strategies. Investigating HPRT function continues to reveal new insights into cellular metabolism and disease mechanisms. HPRT research has significant implications for developing treatments for rare genetic disorders. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of HPRT-related conditions and potential therapeutic approaches.